Clinical trial
Vaccination for Middle Ear Infection
NCT00001605 · National Institute on Deafness and Other Communication Disorders (NIDCD), NIH · Completed
Key facts
| NCT number | NCT00001605 |
|---|---|
| Title | Vaccination for Middle Ear Infection |
| Official title | Phase I Study to Evaluate the Safety and Immunogenicity of a Nontypeable Haemophilus Influenzae Vaccine for Otitis Media |
| Lead sponsor | National Institute on Deafness and Other Communication Disorders (NIDCD), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Otitis Media |
| Intervention type | Biological |
| Interventions | Nontypeable Haemophilus influenzae |
| Enrollment | 40 |
| Start date | May 1, 1997 |
| Completion | Apr 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: